Hospitals have seen reductions in the costs of caring for the uninsured, but nowhere more so than in states that expanded Medicaid.» Read More
President Barack Obama's health care overhaul cleared its second test in the Senate Tuesday. How is Washington action affecting stocks? Sheryl Skolnick, senior VP and health care analyst at Pali Capital, and Les Funtleyder, health care strategist at Miller Tabak, shared their insights.
There is nothing in this bill that changes our views at Soleil regarding the health care stocks we have been recommending.
Buy the IPO, Cramer says, because the company in an industry powerhouse.
The day after President Obama’s impassioned speech for big-government health care, Wall Street bet heavily that the so-called government-insurance option he supports is dead.
Economic news on Tuesday came early and left little impression. The news from overseas was actually more encouraging than the domestic variety
CNBC's "Power Lunch" team asked some of the best and the brightest from America's big financial firms to list the most promising stocks. Strategists from Citigroup, Goldman Sachs, Cowen & Co. and Deutsche Bank offered CNBC their stock picks.
If Democrats pull ahead in the race for the White House the team at Goldman has a trade for you.
As the push for universal health care in the U.S. heats up on Capitol Hill, market experts say generic drug stocks and pharmaceutical distributors should perform well, while the hit to big pharma may not be as bad as some anticipate.
Mergers and acquisitions activity was brisk on Monday, giving stocks a lift as M&A deals spanned several industries, including energy, and added to optimism about the prospects for growth in both corporate profits and the U.S. economy.
Stocks closed solidly higher as investors took encouragement from more than $10 billion of announced acquisitions. "We think the one-day drop of a week or so ago was way overdone," Bob Turner, chief investment officer at Turner Investment Partners, told CNBC. "The trend that's been in place over the last several years of an upward bias to the market is still in place."
The deal, subject to Triad shareholder approval, tops a $4.7 billion agreement announced six weeks ago for Triad to be purchased by CCMP Capital Advisors and Goldman Sachs Capital Partners, the private equity arm of Goldman Sachs Group.
Merger madness is gripping Wall Street this morning and stocks, so far, are ready to sprint higher at the open. European markets are trading higher, and Asian stocks rose overnight, with a weaker yen helping lift Japan's Nikkei more than 1.6%.
Triad Hospitals has accepted a takeover bid from affiliates of CCMP Capital Advisors and GS Capital Partners in a deal worth about $4.7 billion, the company said on Monday